DUBLIN–(BUSINESS WIRE)–Mar 8, 2021–
The North America life science instruments market measurement is anticipated to achieve USD 81.9 billion by 2027 registering a CAGR of 11.6%
The market development is attributed to an increase in authorities funding for all times science applied sciences, development of cell & gene therapies, growing demand for biopharmaceuticals, and an increase in competitors amongst distinguished market entities.
Aggressive dynamics proceed to drive a fast tempo of innovation in sequencing, multiplex platforms, and main classes of mass spectrometry and liquid chromatography; this helps development by way of improve/substitute cycles and expands the applicability of applied sciences. A rise in investments for R&D of life science instruments is anticipated to drive the market considerably.
For example, Thermofisher Scientific, one of many main gamers out there, elevated its R&D expenditure by 7.32% to USD 0.264 billion year-over-year by the quarter ending June 30, 2020. An increase within the variety of strategic offers & developments coupled with the regular business success of biopharmaceuticals is anticipated to speed up market development over the forecast interval.
The Bristol-Myers Squibb/Celgene acquisition (USD 74 billion), AbbVie/Allergan acquisition (USD 63 billion), Takeda/Shire acquisition (USD 58.6 billion), Danaher and GE Biopharma M&A deal (USD 21.4 billion), Amgen/Celgene’s Otezla deal (USD 13.4 billion), and Pfizer/Array Biopharma merger (USD 11.4 billion) had been a few of the largest biopharma merger and acquisition offers of 2019.
Chapter 1 Methodology and Scope
1.3 Info Procurement
1.4 Info or Information Evaluation
1.5 Market Formulation & Validation
1.6.1 Nucleic Acid Preparation market
1.6.2 Cell biology market
220.127.116.11 Comparability of 3D cell tradition strategies
1.6.3 Subsequent-Era Sequencing & Transfection Electroporation market
1.6.4 Market examine, by Know-how
1.6.5 QFD modeling for market share evaluation of applied sciences
1.6.6 Market examine, by finish use
1.7 International Market: CAGR Calculation
Chapter 2 Govt Abstract
Chapter 3 Market Variables, Tendencies, & Scope
3.1.1 Market driver evaluation
18.104.22.168 Elevated authorities funding for all times science applied sciences
22.214.171.124 Development of cell and gene therapies
126.96.36.199 Rise in demand for biopharmaceuticals (biologics and biosimilars)
188.8.131.52 Technological developments in life science instruments
184.108.40.206 Functions of genomic and proteomic applied sciences for precision medication
3.1.2 Market restraint evaluation
220.127.116.11 Excessive value for some applied sciences
18.104.22.168 Dearth of expert professionals
3.1.3 Market alternative evaluation
22.214.171.124 Rise within the variety of strategic offers & developments
3.2 Penetration and Development Prospect Mapping for Know-how, 2019 (USD Million)
3.3 Impression of COVID-19 pandemic on North America Life Science Instruments Market
3.3.1 Impression on the provision chain
3.3.2 Impression on life sciences & healthcare business
3.4 Market Share Evaluation
3.4.3 Strategic Initiatives
3.5 Enterprise Setting Evaluation
3.5.1 SWOT Evaluation; By issue (Political & Authorized, Financial, and Technological)
3.5.2 Porter’s 5 Forces Evaluation
Chapter 4 Know-how Motion Evaluation
4.1 Market: Know-how Motion Evaluation
4.3 Proteomics Know-how
4.4 Cell Biology Know-how
4.5 Different Analytical & Pattern Preparation Know-how
4.6 Lab Provides & Applied sciences
Chapter 5 Product Enterprise Evaluation
5.1 North America Life Science Instruments Market: Product Motion Evaluation
5.2 Subsequent-Era Sequencing
5.2.1 Market estimates and forecast for NGS, 2016-2027 (USD Million)
5.5 Nuclear Magnetic Resonance Spectroscopy (NMR)
5.6 Microscopy & Electron Microscopy
5.7 Liquid Chromatography (LC)
5.8 Mass Spectrometry (MS)
5.9 Nucleic Acid Preparation (NAP)
5.10 Transfection Electroporation
5.13 Different merchandise & companies
5.13.1 Marketplace for different merchandise & companies, 2016-2027 (USD Million)
5.13.4 Nucleic Acid Microarray
126.96.36.199 Marketplace for others, 2016-2027 (USD Million)
Chapter 6 Finish-use Motion Evaluation
6.1 Market: Finish-use Motion Evaluation
6.2 Authorities & Educational
6.3 Biopharmaceutical Firm
6.5 Industrial Utility
Chapter 7 Regional Motion Evaluation
Chapter 8 Firm Profiles
- Thermo Fisher Scientific, Inc.
- F. Hoffmann – La Roche Ltd.
- Illumina, Inc.
- Agilent Applied sciences
- Becton, Dickinson and Firm (BD)
- Bio – Rad Laboratories, Inc.
- Danaher Company
- Common Electrical Firm
- Merck KGaA
- Corning Included
- Perkin Elmer, Inc.
- Miltenyi Biotec
- Hitachi Koki Co., Ltd.
- Shimadzu Company
- Oxford Devices
Laura Wooden, Senior Press Supervisor
For E.S.T Workplace Hours Name 1-917-300-0470
For U.S./CAN Toll Free Name 1-800-526-8630
For GMT Workplace Hours Name +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Analysis and Markets
Copyright Enterprise Wire 2021.
PUB: 03/08/2021 10:08 AM/DISC: 03/08/2021 10:08 AM
Copyright Enterprise Wire 2021.